Share Facebook Twitter Pinterest Email Copy Link Galderma’s shares slumped the most in more than a year after US regulators turned down the Swiss dermatology firm’s rival Botox treatment Relfydess. body-care
US Fashion & Lifestyle François-Henri Bennahmias to Launch New Luxury Swiss Watch Brand N3W5July 1, 2026
